Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Blanco

Showing results (281-290 of 283) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 283 results.
Neurosurgery|June 16, 2026
Volume-Staged Stereotactic Radiosurgery in Pediatric Patients With Large Brain Arteriovenous Malformations: An International, Multicenter StudyBardia Hajikarimloo, Salem M Tos, Robert Ferguson, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Oncogene|December 20, 2016
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibitionF Mateo, E J Arenas, H Aguilar, et al.
Pageof 29

Showing results (281-290 of 283) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 283 results.
Neurosurgery|June 16, 2026
Volume-Staged Stereotactic Radiosurgery in Pediatric Patients With Large Brain Arteriovenous Malformations: An International, Multicenter StudyBardia Hajikarimloo, Salem M Tos, Robert Ferguson, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Oncogene|December 20, 2016
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibitionF Mateo, E J Arenas, H Aguilar, et al.
Pageof 29